trimethyloxamine has been researched along with Atrial Fibrillation in 13 studies
trimethyloxamine: used in manufacture of quaternary ammonium cpds; insect attractant; warming agent for gas; oxidant; structure
trimethylamine N-oxide : A tertiary amine oxide resulting from the oxidation of the amino group of trimethylamine.
Atrial Fibrillation: Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Few studies have examined the associations of trimethylamine-N-oxide (TMAO) and its precursors (choline, betaine, dimethylglycine, and L-carnitine) with the risk of atrial fibrillation (AF) and heart failure (HF)." | 8.02 | Choline Metabolism and Risk of Atrial Fibrillation and Heart Failure in the PREDIMED Study. ( Alonso-Gómez, A; Bulló, M; Clish, C; Corella, D; Estruch, R; Fiol, M; Fitó, M; Guasch-Ferré, M; Hernández-Alonso, P; Hu, FB; Li, J; Liang, L; Martínez-González, MA; Papandreou, C; Ros, E; Ruiz-Canela, M; Salas-Salvadó, J; Santos-Lozano, JM; Serra-Majem, L; Toledo, E, 2021) |
| "Few studies have examined the associations of trimethylamine-N-oxide (TMAO) and its precursors (choline, betaine, dimethylglycine, and L-carnitine) with the risk of atrial fibrillation (AF) and heart failure (HF)." | 4.02 | Choline Metabolism and Risk of Atrial Fibrillation and Heart Failure in the PREDIMED Study. ( Alonso-Gómez, A; Bulló, M; Clish, C; Corella, D; Estruch, R; Fiol, M; Fitó, M; Guasch-Ferré, M; Hernández-Alonso, P; Hu, FB; Li, J; Liang, L; Martínez-González, MA; Papandreou, C; Ros, E; Ruiz-Canela, M; Salas-Salvadó, J; Santos-Lozano, JM; Serra-Majem, L; Toledo, E, 2021) |
| " A dose-response meta-analysis was used to investigate the dose-response relationship between TMAO levels and the risk of AF." | 2.72 | A systematic review and meta-analysis of the gut microbiota-dependent metabolite trimethylamine N-oxide with the incidence of atrial fibrillation. ( Li, XD; Wang, YT; Yang, R; Yang, WT; Zhao, Q, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 8 (61.54) | 2.80 |
| Authors | Studies |
|---|---|
| Yang, WT | 1 |
| Yang, R | 1 |
| Zhao, Q | 1 |
| Li, XD | 1 |
| Wang, YT | 1 |
| Huang, R | 1 |
| Yan, L | 1 |
| Lei, Y | 1 |
| Luo, Y | 1 |
| Zhang, Y | 2 |
| Han, X | 1 |
| Yuan, Y | 1 |
| Zhou, Y | 1 |
| Gao, Y | 1 |
| Yu, H | 1 |
| Zhang, J | 1 |
| Shi, Y | 1 |
| Duan, Y | 1 |
| Zhao, X | 1 |
| Yan, S | 1 |
| Hao, H | 1 |
| Dai, C | 1 |
| Zhao, S | 1 |
| Shi, J | 1 |
| Li, W | 1 |
| Zhang, S | 1 |
| Xu, W | 1 |
| Fang, N | 1 |
| Gong, Y | 1 |
| Li, Y | 1 |
| Jiang, WY | 1 |
| Huo, JY | 1 |
| Wang, SC | 1 |
| Cheng, YD | 1 |
| Lyu, YT | 1 |
| Jiang, ZX | 1 |
| Shan, QJ | 1 |
| Konieczny, R | 1 |
| Żurawska-Płaksej, E | 1 |
| Kaaz, K | 1 |
| Czapor-Irzabek, H | 1 |
| Bombała, W | 1 |
| Mysiak, A | 1 |
| Kuliczkowski, W | 1 |
| Melnychuk, I | 1 |
| Lizogub, VG | 1 |
| Gong, D | 1 |
| Zhang, L | 1 |
| Wang, F | 1 |
| Zhao, Z | 1 |
| Zhou, X | 2 |
| Zuo, K | 1 |
| Liu, X | 1 |
| Wang, P | 1 |
| Jiao, J | 1 |
| Han, C | 1 |
| Liu, Z | 1 |
| Yin, X | 1 |
| Li, J | 2 |
| Yang, X | 1 |
| Papandreou, C | 1 |
| Bulló, M | 1 |
| Hernández-Alonso, P | 1 |
| Ruiz-Canela, M | 1 |
| Guasch-Ferré, M | 1 |
| Toledo, E | 1 |
| Clish, C | 1 |
| Corella, D | 1 |
| Estruch, R | 1 |
| Ros, E | 1 |
| Fitó, M | 1 |
| Alonso-Gómez, A | 1 |
| Fiol, M | 1 |
| Santos-Lozano, JM | 1 |
| Serra-Majem, L | 1 |
| Liang, L | 1 |
| Martínez-González, MA | 1 |
| Hu, FB | 1 |
| Salas-Salvadó, J | 1 |
| Yu, L | 1 |
| Meng, G | 1 |
| Huang, B | 1 |
| Stavrakis, S | 1 |
| Wang, M | 2 |
| Li, X | 1 |
| Zhou, L | 1 |
| Wang, Y | 1 |
| Wang, Z | 1 |
| Deng, J | 1 |
| Po, SS | 1 |
| Jiang, H | 1 |
| Svingen, GFT | 1 |
| Zuo, H | 1 |
| Ueland, PM | 1 |
| Seifert, R | 1 |
| Løland, KH | 1 |
| Pedersen, ER | 1 |
| Schuster, PM | 1 |
| Karlsson, T | 1 |
| Tell, GS | 1 |
| Schartum-Hansen, H | 1 |
| Olset, H | 1 |
| Svenningsson, M | 1 |
| Strand, E | 1 |
| Nilsen, DW | 1 |
| Nordrehaug, JE | 1 |
| Dhar, I | 1 |
| Nygård, O | 1 |
| Liang, Z | 1 |
| Dong, Z | 1 |
| Guo, M | 1 |
| Shen, Z | 1 |
| Yin, D | 1 |
| Hu, S | 1 |
| Hai, X | 1 |
| Lin, T | 1 |
| Li, K | 1 |
| He, W | 1 |
| Chen, L | 1 |
| Wang, T | 1 |
| Wang, N | 1 |
2 reviews available for trimethyloxamine and Atrial Fibrillation
| Article | Year |
|---|---|
A systematic review and meta-analysis of the gut microbiota-dependent metabolite trimethylamine N-oxide with the incidence of atrial fibrillation.
Topics: Atrial Fibrillation; Gastrointestinal Microbiome; Humans; Incidence; Methylamines; Risk Factors | 2021 |
The Gut Microbial-Derived Metabolite Trimethylamine N-Oxide and Atrial Fibrillation: Relationships, Mechanisms, and Therapeutic Strategies.
Topics: Atrial Fibrillation; Gastrointestinal Microbiome; Humans; Metabolic Networks and Pathways; Methylami | 2021 |
1 trial available for trimethyloxamine and Atrial Fibrillation
| Article | Year |
|---|---|
Trimethylamine N-oxide as a risk marker for ischemic stroke in patients with atrial fibrillation.
Topics: Aged; Atrial Fibrillation; Biomarkers; Brain Ischemia; Female; Humans; Male; Methylamines; Middle Ag | 2019 |
10 other studies available for trimethyloxamine and Atrial Fibrillation
| Article | Year |
|---|---|
Akkermansia muciniphila prevents cold-related atrial fibrillation in rats by modulation of TMAO induced cardiac pyroptosis.
Topics: Adolescent; Akkermansia; Animals; Atrial Fibrillation; Cross-Sectional Studies; Humans; Methylamines | 2022 |
Trimethylamine N-oxide facilitates the progression of atrial fibrillation in rats with type 2 diabetes by aggravating cardiac inflammation and connexin remodeling.
Topics: Animals; Atrial Fibrillation; Atrial Remodeling; Connexins; Diabetes Mellitus, Experimental; Diabete | 2022 |
All-Cause Mortality and Trimethylamine N-Oxide Levels in Patients with Cardiovascular Disease.
Topics: Atrial Fibrillation; Biomarkers; Cardiovascular Diseases; Female; Heart Failure; Humans; Male; Methy | 2022 |
GUT MICROBIOTA COMPOSITION AND ITS METABOLITES CHANGES IN PATIENTS WITH ATHEROSCLEROSIS AND ATRIAL FIBRILLATION.
Topics: Atherosclerosis; Atrial Fibrillation; Bacteria; Gastrointestinal Microbiome; Humans | 2022 |
Gut Microbial Metabolite Trimethylamine N-Oxide Is Related to Thrombus Formation in Atrial Fibrillation Patients.
Topics: Atrial Fibrillation; Female; Gastrointestinal Microbiome; Humans; Male; Methylamines; Middle Aged; P | 2019 |
Metagenomic data-mining reveals enrichment of trimethylamine-N-oxide synthesis in gut microbiome in atrial fibrillation patients.
Topics: Atrial Fibrillation; Data Mining; Gastrointestinal Microbiome; Humans; Methylamines; Oxides | 2020 |
Choline Metabolism and Risk of Atrial Fibrillation and Heart Failure in the PREDIMED Study.
Topics: Aged; Atrial Fibrillation; Betaine; Carnitine; Case-Control Studies; Choline; Female; Heart Failure; | 2021 |
A potential relationship between gut microbes and atrial fibrillation: Trimethylamine N-oxide, a gut microbe-derived metabolite, facilitates the progression of atrial fibrillation.
Topics: Animals; Atrial Fibrillation; Disease Progression; Dogs; Gastrointestinal Microbiome; Heart Atria; I | 2018 |
Increased plasma trimethylamine-N-oxide is associated with incident atrial fibrillation.
Topics: Aged; Atrial Fibrillation; Choline; Female; Follow-Up Studies; Humans; Incidence; Male; Methylamines | 2018 |
Trimethylamine N-oxide: A new therapeutic target for atrial fibrillation?
Topics: Atrial Fibrillation; Humans; Methylamines | 2019 |